- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,509GBP
- Report
- October 2026
- 563 Pages
Global
From €5378EUR$5,850USD£4,572GBP
- Report
- August 2026
- 160 Pages
Global
From €3052EUR$3,320USD£2,595GBP
€3815EUR$4,150USD£3,243GBP
- Report
- May 2026
- 355 Pages
Global
From €5295EUR$5,962USD£4,350GBP
- Report
- January 2026
- 314 Pages
Global
From €5295EUR$5,962USD£4,350GBP
- Report
- August 2026
- 248 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- March 2026
- 248 Pages
Global
From €4411EUR$4,799USD£3,751GBP
- Report
- August 2026
- 440 Pages
Global
From €4550EUR$4,950USD£3,869GBP
- Report
- April 2026
Global
From €4504EUR$4,900USD£3,830GBP
- Report
- September 2026
- 192 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 192 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 197 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 199 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 181 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 184 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 199 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 184 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 187 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP
- Report
- September 2026
- 199 Pages
Global
From €3259EUR$3,545USD£2,771GBP
€3621EUR$3,939USD£3,079GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more